Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Validea
$12.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Patterson Companies Inc Reaffirms FY 2014 EPS Guidance


Thursday, 21 Nov 2013 07:00am EST 

Patterson Companies Inc reaffirmed fiscal 2014 earnings guidance to a range of $2.13 to $2.24 per diluted share (EPS), which includes the anticipated $0.03 to $0.04 per diluted share benefit from the NVS acquisition. The new guidance range excludes the non-recurring restructuring charge for Patterson Medical of approximately $0.12 per diluted share. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.17 for fiscal 2014. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $2.18 for fiscal 2014. 

Company Quote

46.39
0.45 +0.98%
28 Aug 2015